The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Liver fibrosis
Open accessAbstract
Liver fibrosis is a wound-healing response generated against an insult to the liver that causes liver injury. It has the potential to progress into cirrhosis, and if not prevented, it may lead to liver cancer and liver failure. The activation of hepatic stellate cells (HSCs) is the central event underlying liver fibrosis. In addition to HSCs, numerous studies have supported the potential contribution of bone marrow-derived cells and myofibroblasts to liver fibrosis. The liver is a heterogeneous organ; thus, molecular and cellular events that underlie liver fibrogenesis are complex. This review aims to focus on major events that occur during liver fibrogenesis. In addition, important antifibrotic therapeutic approaches and experimental liver fibrosis models will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075
Yamaguchi, K., Yang, L., McCall, S., Huang, J., Yu, X. X., Pandey, S. K., Bhanot, S., Monia, B. P., Li, Y.-X., & Diehl, A. M. (2007) · Hepatology · doi:10.1002/hep.21655 · Cited by 1,015
Mechanisms of hepatic fibrogenesis
Lee, U. E., & Friedman, S. L. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.005 · Cited by 923
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
Iredale, J. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30542 · Cited by 866
Roles for chemokines in liver disease
Marra, F., & Tacke, F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.06.043 · Cited by 829
Non-Cell-Autonomous Tumor Suppression by p53
Lujambio, A., Akkari, L., Simon, J., Grace, D., Tschaharganeh, D. F., Bolden, J. E., Zhao, Z., Thapar, V., Joyce, J. A., Krizhanovsky, V., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.020 · Cited by 766
Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research
Anstee, Q. M., & Goldin, R. D. (2006) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2006.00465.x · Cited by 714
Hernández–Gea, V., Ghiassi–Nejad, Z., Rozenfeld, R., Gordon, R., Fiel, M. I., Yue, Z., Czaja, M. J., & Friedman, S. L. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.044 · Cited by 654
Baeck, C., Wehr, A., Karlmark, K. R., Heymann, F., Vucur, M., Gassler, N., Huss, S., Klussmann, S., Eulberg, D., Luedde, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300304 · Cited by 609
Inhibition of hepatitis B virus in mice by RNA interference
McCaffrey, A. P., Nakai, H., Pandey, K., Huang, Z., Salazar, F. H., Xu, H., Wieland, S. F., Marion, P. L., & Kay, M. A. (2003) · Nature Biotechnology · doi:10.1038/nbt824 · Cited by 607
Hidvegi, T., Ewing, M., Hale, P., Dippold, C., Beckett, C., Kemp, C., Maurice, N., Mukherjee, A., Goldbach, C., Watkins, S., et al. (2010) · Science · doi:10.1126/science.1190354 · Cited by 607
Fernández, M., Semela, D., Bruix, J., Colle, I., Pinzani, M., & Bosch, J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.011 · Cited by 600
Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets
Zhang, C.-Y., Yuan, W.-G., He, P., Lei, J.-H., & Wang, C.-X. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i48.10512 · Cited by 594
Lipson, K. E., Wong, C., Teng, Y., & Spong, S. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s24 · Cited by 575
Matrix as a Modulator of Hepatic Fibrogenesis
Schuppan, D., Ruehl, M., Somasundaram, R., & Hahn, E. G. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-17556 · Cited by 542
Origin of myofibroblasts in the fibrotic liver in mice
Iwaisako, K., Jiang, C., Zhang, M., Cong, M., Moore-Morris, T. J., Park, T. J., Liu, X., Xu, J., Wang, P., Paik, Y.-H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400062111 · Cited by 535
Verna, L. (1996) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(96)00062-9 · Cited by 508
Kisseleva, T., & Brenner, D. A. (2008) · Experimental Biology and Medicine · doi:10.3181/0707-mr-190 · Cited by 503
Mechanisms of Disease: mechanisms of hepatic fibrosis and therapeutic implications
Friedman, S. L. (2004) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0055 · Cited by 498
Fallowfield, J. A., Mizuno, M., Kendall, T. J., Constandinou, C. M., Benyon, R. C., Duffield, J. S., & Iredale, J. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5288 · Cited by 479
Adipokines in liver diseases #
Marra, F., & Bertolani, C. (2009) · Hepatology · doi:10.1002/hep.23046 · Cited by 471
Fickert, P., Fuchsbichler, A., Wagner, M., Zollner, G., Kaser, A., Tilg, H., Krause, R., Lammert, F., Langner, C., Zatloukal, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.009 · Cited by 468
Rinella, M. E., & Green, R. M. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.09.020 · Cited by 460
The Basement Membrane Component of Biologic Scaffolds Derived from Extracellular Matrix
Brown, B., Lindberg, K., Reing, J., Stolz, D. B., & Badylak, S. F. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.519 · Cited by 436
Leptin is essential for the hepatic fibrogenic response to chronic liver injury
Leclercq, I. A., Farrell, G. C., Schriemer, R., & Robertson, G. R. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00102-2 · Cited by 407
Th, M., van Nieuwkerk, C. M., Dingemans, K. P., Smit, J. J., Schinkel, A. H., Notenboom, R. G. E., Weerman, M. A. V. D. B., VERKRUISEN, R. P., Groen, A. K., & Elferink, R. P. J. O. (1994) · PubMed · Cited by 403
Experimental models of liver fibrosis
Crespo Yanguas, S., Cogliati, B., Willebrords, J., Maes, M., Colle, I., van den Bossche, B., de Oliveira, C. P. M. S., Andraus, W., Alves, V. A., Leclercq, I., et al. (2016) · Archives of Toxicology · doi:10.1007/s00204-015-1543-4 · Cited by 350
Animal models of NASH: Getting both pathology and metabolic context right
Larter, C. Z., & Yeh, M. M. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05543.x · Cited by 337
Hepatic Stellate Cell Behavior during Resolution of Liver Injury
Iredale, J. P. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-17557 · Cited by 333
Jeong, W.-I., Osei-Hyiaman, D., Park, O., Liu, J., Bátkai, S., Mukhopadhyay, P., Horiguchi, N., Harvey-White, J., Marsicano, G., Lutz, B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.007 · Cited by 310
Wong, L., Yamasaki, G., Johnson, R. J., & Friedman, S. L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117497 · Cited by 304
Recent advancement of molecular mechanisms of liver fibrosis
Seki, E., & Brenner, D. A. (2015) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.245 · Cited by 300
Zhan, S.-S., Jiang, J. X., Wu, J., Halsted, C., Friedman, S. L., Zern, M. A., & Torok, N. J. (2006) · Hepatology · doi:10.1002/hep.21093 · Cited by 284
Reversibility of liver fibrosis
Sun, M., & Kisseleva, T. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.06.015 · Cited by 274
Chisari, F. V., Filippi, P., McLachlan, A., Milich, D. R., Riggs, M., Lee, S., Palmiter, R. D., Pinkert, C. A., & Brinster, R. L. (1986) · Journal of Virology · doi:10.1128/jvi.60.3.880-887.1986 · Cited by 269
Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat
Iimuro, Y., Nishio, T., Morimoto, T., Nitta, T., Stefanovic, B., Choi, S. K., Brenner, D. A., & Yamaoka, Y. (2003) · Gastroenterology · doi:10.1053/gast.2003.50063 · Cited by 263
Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9
Watanabe, A., Hashmi, A., Gomes, D. A., Town, T., Badou, A., Flavell, R. A., & Mehal, W. Z. (2007) · Hepatology · doi:10.1002/hep.21867 · Cited by 262
Human Hepatic Stellate Cells Express CCR5 and RANTES to Induce Proliferation and Migration
Schwabe, R. F., Bataller, R., & Brenner, D. A. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00215.2003 · Cited by 252
New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis
Wang, Y., Gao, J., Zhang, D., Zhang, J., Ma, J., & Jiang, H. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.027 · Cited by 231
Guimarães, E. L. M., Empsen, C., Geerts, A., & van Grunsven, L. A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.007 · Cited by 226
Schnabl, B., Purbeck, C. A., Choi, Y. H., Hagedorn, C. H., & Brenner, D. (2003) · Hepatology · doi:10.1053/jhep.2003.50097 · Cited by 224
Guo, J., Loke, J., Zheng, F., Hong, F., Yea, S., Fukata, M., Tarocchi, M., Abar, O. T., Huang, H., Sninsky, J. J., et al. (2009) · Hepatology · doi:10.1002/hep.22697 · Cited by 217
Hypoxia: A Link between Fibrogenesis, Angiogenesis, and Carcinogenesis in Liver Disease
Rosmorduc, O., & Housset, C. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255355 · Cited by 208
Patsenker, E., Popov, Y., Stickel, F., Jonczyk, A., Goodman, S. L., & Schuppan, D. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.009 · Cited by 200
Recent advances in pericyte biology--implications for health and disease.
Sims, D. (1991) · PubMed · Cited by 199
Kelly, J. D., Haldeman, B. A., Grant, F. J., Murray, M. J., Seifert, R. A., Bowen-Pope, D. F., Cooper, J. A., & Kazlauskas, A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31541-2 · Cited by 194
A Role for Serotonin (5-HT) in Hepatic Stellate Cell Function and Liver Fibrosis
Ruddell, R. G., Oakley, F., Hussain, Z., Yeung, I., Bryan-Lluka, L. J., Ramm, G. A., & Mann, D. A. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050767 · Cited by 194
Mechanisms and cell signaling in alcoholic liver disease
Beier, J. I., & McClain, C. J. (2010) · Biological Chemistry · doi:10.1515/bc.2010.137 · Cited by 178
TGF-β/Smad Signaling in the Injured Liver
Breitkopf, K., Godoy, P., Ciuclan, L., Singer, M., & Dooley, S. (2006) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2005-858989 · Cited by 176
Liu, C., Tao, Q., Sun, M., Wu, J. Z., Yang, W., Jian, P., Peng, J., Hu, Y., Liu, C., & Liu, P. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.123 · Cited by 166
A proteomic analysis of thioacetamide‐induced hepatotoxicity and cirrhosis in rat livers
Low, T. Y., Leow, C. K., Salto‐Tellez, M., & Chung, M. C. M. (2004) · PROTEOMICS · doi:10.1002/pmic.200400852 · Cited by 164
Angiogenesis and liver fibrosis
Elpek, G. Ö. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.377 · Cited by 163
Toll-like Receptor 4 and Hepatic Fibrogenesis
Pradere, J.-P., Troeger, J., Dapito, D., Mencin, A., & Schwabe, R. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255353 · Cited by 158
Jiang, J. X., Mikami, K., Venugopal, S., Li, Y., & Török, N. J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.024 · Cited by 158
Reversibility of liver fibrosis
Pellicoro, A., Ramachandran, P., & Iredale, J. P. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s26 · Cited by 135
Sánchez-Pérez, Y., Legleu, C. E. C., García-Cuellar, C. M., Pérez‐Carreón, J. I., Hernández-García, S., Salcido-Neyoy, M. E., Alemán‐Lazarini, L., & Villa‐Treviño, S. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.07.019 · Cited by 128
Amelioration of hepatic fibrosis by NK cell activation
Muhanna, N., Tair, L. A., Doron, S., Amer, J., Azzeh, M., Mahamid, M., Friedman, S., & Safadi, R. (2011) · Gut · doi:10.1136/gut.2010.211136 · Cited by 127
Win, K. M., Charlotte, F., Mallat, A., Cherqui, D., Martin, N., Mavier, P., Préaux, A.-M., Dhumeaux, D., & Rosenbaum, J. (1993) · PubMed · Cited by 125
Clinical Advancements in the Targeted Therapies against Liver Fibrosis
Bansal, R., Nagórniewicz, B., & Prakash, J. (2016) · Mediators of Inflammation · doi:10.1155/2016/7629724 · Cited by 112
Reversibility of liver fibrosis
Ramachandran, P., & Iredale, J. P. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31740-5 · Cited by 110
Functional role of chemokines in liver disease models
Sahin, H., Trautwein, C., & Wasmuth, H. E. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.168 · Cited by 107
Mukhopadhyay, B., Liu, J., Osei‐Hyiaman, D., Godlewski, G., Mukhopadhyay, P., Wang, L., Jeong, W., Gao, B., Duester, G., Mackie, K., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.068460 · Cited by 107
Meyer, D. H., Bachem, M. G., & Gressner, A. M. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90801-s · Cited by 106
Role of adipose tissue in methionine–choline-deficient model of non-alcoholic steatohepatitis (NASH)
Jha, P., Knopf, A., Köfeler, H. C., Mueller, M., Lackner, C., Höefler, G., Claudel, T., & Trauner, M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.02.012 · Cited by 105
Li, Z., Oben, J. A., Yang, S., Lin, H., Stafford, E. A., Soloski, M. J., THOMAS, S. A., & Diehl, A. M. (2004) · Hepatology · doi:10.1002/hep.20320 · Cited by 103
Win, K. M., Charlotte, F., Mallat, A., Cherqui, D., Martin, N., Mavier, P., Preaux, A.-M., Dhumeau, D., & Rosenbaum, J. (1993) · Hepatology · doi:10.1002/hep.1840180121 · Cited by 102
Role of adipocytokines in hepatic fibrogenesis
Ikejima, K., Okumura, K., Kon, K., Takei, Y., & Sato, N. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04961.x · Cited by 98
Denda, A., Kitayama, W., Kishida, H., Murata, N., Tsutsumi, M., Tsujiuchi, T., Nakae, D., & Konishi, Y. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01250.x · Cited by 93
Ichimura‐Shimizu, M., Kawase, M., Masuzumi, M., Sakaki, M., Nagata, Y., Tanaka, K., Suruga, K., Tamaru, S., Kato, S., Tsuneyama, K., et al. (2014) · Hepatology Research · doi:10.1111/hepr.12358 · Cited by 92
Hepatic Stellate Cells and Liver Fibrosis
Puche, J. E., Saiman, Y., & Friedman, S. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00529.x · Cited by 89
Animal models for the study of liver fibrosis: new insights from knockout mouse models
Hayashi, H., & Sakai, T. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00013.2011 · Cited by 88
Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imaging
Li, D., He, L., Guo, H., Chen, H., & Shan, H. (2015) · EJNMMI Research · doi:10.1186/s13550-015-0151-x · Cited by 80
Inflammation in response to hepatocellular apoptosis
Jaeschke, H. (2002) · Hepatology · doi:10.1053/jhep.2002.0350964 · Cited by 78
Reversibility and heritability of liver fibrosis: Implications for research and therapy
Atta, H. M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i17.5138 · Cited by 72
Angiogenesis: From Chronic Liver Inflammation to Hepatocellular Carcinoma
Sanz-Cameno, P., Trapero-Marugán, M., Chaparro, M., Jones, E. A., & Moreno‐Otero, R. (2010) · Journal of Oncology · doi:10.1155/2010/272170 · Cited by 64
Park, K. C., Park, J. H., Jeon, J. Y., Kim, S. Y., Kim, J. M., Lim, C. Y., Lee, T. H., Kim, H. K., Lee, H. G., Kim, S. M., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12590 · Cited by 63
Controversies over the Epithelial-to-Mesenchymal Transition in Liver Fibrosis
Taura, K., Iwaisako, K., Hatano, E., & Üemoto, S. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5010009 · Cited by 59
Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo
Minicis, S. D., Candelaresi, C., Marzioni, M., Saccomano, S., Roskams, T., Casini, A., Risaliti, A., Salzano, R., Cautero, N., di Francesco, F., et al. (2007) · Gut · doi:10.1136/gut.2007.120303 · Cited by 53
Reversibility of liver fibrosis.
Brenner, D. A. (2013) · Europe PMC (PubMed Central) · Cited by 45
Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease
Larter, C. Z., Yeh, M. M., Haigh, W. G., Rooyen, D. M. V., Brooling, J. T., Heydet, D., Nolan, C. J., Teoh, N., & Farrell, G. C. (2013) · Obesity · doi:10.1002/oby.20123 · Cited by 41
Zvibel, I., Atias, D., Phillips, A. T., Halpern, Z., & Oren, R. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.48 · Cited by 37
Oh, S., Kim, D., Ha, J.-R., & Kim, D.-Y. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1364 · Cited by 17
Aparicio‐Bautista, D. I., Pérez‐Carreón, J. I., Gutiérrez-Nájera, N., Reyes‐Grajeda, J. P., Arellanes‐Robledo, J., Vásquez-Garzón, V. R., Jiménez-García, M. N., & Villa‐Treviño, S. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.08.005 · Cited by 14
Cited by
Macrophage Polarization and Its Role in Liver Disease
Wang, C., Ma, C., Gong, L., Guo, Y., Fu, K., Zhang, Y., Zhou, H., & Li, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.803037 · Cited by 581
The Space of Disse: The Liver Hub in Health and Disease
Sanz-García, C., Fernández-Iglesias, A., Gracia-Sancho, J., Arráez-Aybar, L. A., Nevzorova, Y. A., & Cubero, F. J. (2021) · Livers · doi:10.3390/livers1010002 · Cited by 57
Azizsoltani, A., Hatami, B., Zali, M. R., Mahdavi, V., Baghaei, K., & Alizadeh, E. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115777 · Cited by 40
Liu, Y., He, C.-Y., Yang, X.-M., Chen, W.-C., Zhang, M.-J., Zhong, X.-D., Chen, W.-G., Zhong, B.-L., He, S.-Q., & Sun, H.-T. (2023) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x2350057x · Cited by 38
Deng, J.-W., Yuan, S., Shi, L.-P., Chen, X., Liu, J., Chen, Z.-W., Tan, K.-Y., Yang, Q., & Cao, W.-F. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117730 · Cited by 12
Metadata
- Authors
- Aydin, M. M., & Akcali, K. C.
- Venue
- The Turkish Journal of Gastroenterology
- Publisher
- AVES YAYINCILIK A.Ş.
- Published
- 2018-01-31
- Volume
- 29
- Issue
- 1
- Pages
- 14-21
- ISSN
- 1300-4948 (ISSN-L)
- 2148-5607
- OpenAlex
- W4248328427
- Cited by
- 381
- References
- 88
- FWCI
- 12.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.